Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127809601 | 12780960 | 1 | I | 20160902 | 20160926 | 20160926 | EXP | US-PFIZER INC-2016428374 | PFIZER | COURVILLE, EL.. PATIENTS WITH A HISTORY OF CHEMOTHERAPY AND ISOLATED DEL(20Q) WITH MINIMAL MYELODYSPLASIA HAVE AN INDOLENT COURSE.. AM. J. CLIN. PATHOL.. 2016;145:459-466 | 23.00 | YR | M | Y | 0.00000 | 20160926 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127809601 | 12780960 | 1 | PS | DOXORUBICIN HCL | DOXORUBICIN HYDROCHLORIDE | 1 | UNK | U | 50467 | ||||||||||
| 127809601 | 12780960 | 2 | SS | BLEOMYCIN SULFATE | BLEOMYCIN SULFATE | 1 | UNK | U | 65031 | ||||||||||
| 127809601 | 12780960 | 3 | SS | CYTARABINE. | CYTARABINE | 1 | UNK | U | 71868 | ||||||||||
| 127809601 | 12780960 | 4 | SS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | UNK | U | 78339 | ||||||||||
| 127809601 | 12780960 | 5 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | UNK | U | 71484 | ||||||||||
| 127809601 | 12780960 | 6 | SS | LEUNASE | ASPARAGINASE | 1 | UNK | U | 0 | INJECTION | |||||||||
| 127809601 | 12780960 | 7 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | UNK | U | 0 | ||||||||||
| 127809601 | 12780960 | 8 | SS | PREDNISONE. | PREDNISONE | 1 | UNK | U | 0 | ||||||||||
| 127809601 | 12780960 | 9 | SS | VINBLASTINE | VINBLASTINE | 1 | UNK | U | 0 | ||||||||||
| 127809601 | 12780960 | 10 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | UNK | U | 0 | ||||||||||
| 127809601 | 12780960 | 11 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | UNK | U | 0 | ||||||||||
| 127809601 | 12780960 | 12 | SS | CISPLATIN. | CISPLATIN | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127809601 | 12780960 | 1 | Hodgkin's disease |
| 127809601 | 12780960 | 2 | Hodgkin's disease |
| 127809601 | 12780960 | 3 | Hodgkin's disease |
| 127809601 | 12780960 | 4 | Hodgkin's disease |
| 127809601 | 12780960 | 5 | Hodgkin's disease |
| 127809601 | 12780960 | 6 | Hodgkin's disease |
| 127809601 | 12780960 | 7 | Hodgkin's disease |
| 127809601 | 12780960 | 8 | Hodgkin's disease |
| 127809601 | 12780960 | 9 | Hodgkin's disease |
| 127809601 | 12780960 | 10 | Hodgkin's disease |
| 127809601 | 12780960 | 11 | Hodgkin's disease |
| 127809601 | 12780960 | 12 | Hodgkin's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127809601 | 12780960 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127809601 | 12780960 | Myelodysplastic syndrome | |
| 127809601 | 12780960 | Second primary malignancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |